ACE2 and metabolic dysfunction-associated steatotic liver disease: Recently, Meijnikman et al. [73] reported that ACE2 is upregulated in the subcutaneous and visceral adipose tissues and liver tissue of individuals with NAFLD; fostering viral penetration into cells identified an additional mechanism that contributes to increased susceptibility to severe COVID-19 in individuals with NAFLD.